The survival of bacteria in toxic environments is facilitated by intrinsic and acquired genes. One chromosomal region, the multiple antibiotic resistance chromosomal (mar) locus, is induced by a number of structurally unrelated compounds and by low pH. It provides resistance to antibiotics, disinfectants, organic solvents, and oxidative stress. The MarA transcriptional activator regulates a diverse group of genes comprising the Mar regulon. MarR represses the marRAB operon locus. The investigators propose to further investigate the mar locus and the mar regulon. Purification of MarR and MarA has been accomplished. Studies are proposed to determine the functional domains of MarR (repressor) and MarA (activator). For structural determination, X-ray crystallography and 2-D NMR studies will be performed. Since MarR and MarA are members of large protein families, work on these proteins should impact other areas of bacterial ecology and metabolism. They shall identify further mar-regulated (mlr) genes and their functions. Additional conditions which induce the mar operon or its targets will be sought. These results will enhance our understanding of the role of this complex regulon in adaptation of the bacterial cell to its environment. The functioning of the E. coli MarA protein in Mycobacterium smegmatis and the discovery of M. smegmatis Mar mutants has prompted a search for functional marA homologs in this genus. The frequency of Mar mutants in the environment will be observed to complement findings of Mar mutants among clinical E. coli isolates. The role that the mar locus plays (e.g., in quinolone resistance), when transiently expressed upon induction by salicylate, will be investigated. As bacteria emerge increasingly with multiple drug resistance, the role of regulatory loci such as mar in producing drug resistance has become of greater interest. Studies of the mar locus and its regulon will improve general understanding of how bacteria sense and respond to different environmental signals and allow identification of similar response systems in other bacteria of importance to public health.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM051661-16
Application #
6019035
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Anderson, James J
Project Start
1980-09-30
Project End
2002-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Tufts University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Schneiders, Thamarai; Barbosa, Teresa M; McMurry, Laura M et al. (2004) The Escherichia coli transcriptional regulator MarA directly represses transcription of purA and hdeA. J Biol Chem 279:9037-42
Bina, Xiaowen; Perreten, Vincent; Levy, Stuart B (2003) The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli. J Bacteriol 185:1465-9
Schneiders, T; Amyes, S G B; Levy, S B (2003) Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob Agents Chemother 47:2831-7
Koutsolioutsou, A; Martins, E A; White, D G et al. (2001) A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrob Agents Chemother 45:38-43
Perreten, V; Schwarz, F V; Teuber, M et al. (2001) Mdt(A), a new efflux protein conferring multiple antibiotic resistance in Lactococcus lactis and Escherichia coli. Antimicrob Agents Chemother 45:1109-14
Wang, H; Dzink-Fox, J L; Chen, M et al. (2001) Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob Agents Chemother 45:1515-21
Alekshun, M N; Kim, Y S; Levy, S B (2000) Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol Microbiol 35:1394-404
Oethinger, M; Kern, W V; Jellen-Ritter, A S et al. (2000) Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 44:3-Oct
Kern, W V; Oethinger, M; Jellen-Ritter, A S et al. (2000) Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob Agents Chemother 44:814-20
Barbosa, T M; Levy, S B (2000) Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 182:3467-74

Showing the most recent 10 out of 23 publications